51.99 (0.29%)
As of Oct 19, 2022
Source:
ChemoCentryx is a biopharmaceutical company focused on the development and commercialization of new medications targeting inflammatory disorders, autoimmune diseases and cancer. Each of our drug candidates is designed to selectively block a specific chemoattractant receptor, leaving the rest of the immune system intact. Our drug candidates are small molecules, which are orally administered, and, if approved, could address unmet medical needs, including improved efficacy, and offer significant quality of life benefits.
Country | United States |
Headquarters | san carlos, california |
Phone Number | 650-210-2900 |
Industry | manufacturing |
CEO | Thomas J. Schall, Ph.D. |
Website | chemocentryx.com |